Menu
Back to User profile » Dr Tao Peng
Papers published by Dr Tao Peng:
Hepatic Artery Infusion Chemotherapy Sequential Hepatic Artery Embolization Combined with Operation in the Treatment of Recurrent Massive Hepatocellular Carcinoma Achieved Pathological Complete Response: A Case Report
Chen J, Liao X, Wu Y, Ou S, Qin W, Yang C, Tan Y, Lao Q, Peng M, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:949-958
Published Date: 1 November 2023
RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma
Wei Y, Lan C, Wang X, Zhou X, Liao X, Huang H, Wei Z, Li T, Peng T, Zhu G
International Journal of General Medicine 2023, 16:4377-4392
Published Date: 26 September 2023
PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
Lan C, Huang X, Liao X, Zhou X, Peng K, Wei Y, Han C, Peng T, Wang J, Zhu G
Pharmacogenomics and Personalized Medicine 2023, 16:337-355
Published Date: 15 April 2023
Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
Wu Y, Ou S, Liao X, Han C, Yang C, Qin W, Tan Y, Lao Q, Peng T, Ye X
Pharmacogenomics and Personalized Medicine 2023, 16:111-120
Published Date: 7 February 2023
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy
Huang H, Liao X, Zhu G, Han C, Wang X, Yang C, Zhou X, Liang T, Huang K, Peng T
Pharmacogenomics and Personalized Medicine 2022, 15:277-300
Published Date: 29 March 2022
High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma
Wei YG, Yang CK, Wei ZL, Liao XW, He YF, Zhou X, Huang HS, Lan CL, Han CY, Peng T
International Journal of General Medicine 2022, 15:609-621
Published Date: 14 January 2022
CYP2C8 Suppress Proliferation, Migration, Invasion and Sorafenib Resistance of Hepatocellular Carcinoma via PI3K/Akt/p27kip1 Axis
Zhou X, Li TM, Luo JZ, Lan CL, Wei ZL, Fu TH, Liao XW, Zhu GZ, Ye XP, Peng T
Journal of Hepatocellular Carcinoma 2021, 8:1323-1338
Published Date: 3 November 2021
Circulating tumor cells as a potential biomarker for postoperative clinical outcome in HBV-related hepatocellular carcinoma
Ye X, Li G, Han C, Han Q, Shang L, Su H, Han B, Gong Y, Lu GD, Peng T
Cancer Management and Research 2018, 10:5639-5647
Published Date: 15 November 2018
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q, Peng T
Cancer Management and Research 2018, 10:3255-3271
Published Date: 5 September 2018
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Wang X, Huang K, Yang C, Yu T, Han C, Zhu G, Su H, Huang R, Peng T
Cancer Management and Research 2018, 10:2537-2551
Published Date: 10 August 2018
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma
Yu T, Wang X, Zhu G, Han C, Su H, Liao X, Yang C, Qin W, Huang K, Peng T
Cancer Management and Research 2018, 10:1713-1726
Published Date: 25 June 2018
Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population
Ye X, Wang X, Shang L, Zhu G, Su H, Han C, Qin W, Li G, Peng T
Cancer Management and Research 2018, 10:1037-1050
Published Date: 4 May 2018
Genetic variants in the exon region of versican predict survival of patients with resected early-stage hepatitis B virus-associated hepatocellular carcinoma
Liu X, Han C, Liao X, Yu L, Zhu G, Su H, Qin W, Lu S, Ye X, Peng T
Cancer Management and Research 2018, 10:1027-1036
Published Date: 4 May 2018
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma
Liao X, Yu L, Liu X, Han C, Yu T, Qin W, Yang C, Zhu G, Su H, Peng T
Cancer Management and Research 2018, 10:953-967
Published Date: 1 May 2018
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinoma
Liao X, Zhu G, Huang R, Yang C, Wang X, Huang K, Yu T, Han C, Su H, Peng T
Cancer Management and Research 2018, 10:787-803
Published Date: 13 April 2018
Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma
Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T
Cancer Management and Research 2018, 10:679-696
Published Date: 10 April 2018
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy
Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T
OncoTargets and Therapy 2017, 10:4493-4506
Published Date: 12 September 2017
Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma
Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T
OncoTargets and Therapy 2017, 10:3719-3732
Published Date: 24 July 2017